Insulin aspart, recombinant Subcutaneous and Pregabalin Extended-Release Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pregabalin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pregabalin
Brand name: Lyrica, Lyrica CR
Synonyms: Pregabalin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pregabalin Oral Solution
- Insulin aspart, recombinant Subcutaneous-Pregnyl
- Insulin aspart, recombinant Subcutaneous-Pregnyl injectable
- Insulin aspart, recombinant Subcutaneous-Prelidopine Pre-Operative System
- Insulin aspart, recombinant Subcutaneous-Prelone
- Insulin aspart, recombinant Subcutaneous-Prelu-2
- Pregabalin Extended-Release Tablets-Insulin degludec
- Pregabalin Extended-Release Tablets-Insulin Degludec (U-100) Prefilled Pens
- Pregabalin Extended-Release Tablets-Insulin Degludec (U-100) Vials
- Pregabalin Extended-Release Tablets-Insulin Degludec (U-200) Prefilled Pens
- Pregabalin Extended-Release Tablets-Insulin degludec and liraglutide
- Pregabalin Extended-Release Tablets-Insulin degludec and liraglutide Subcutaneous